Remove 2023 Remove Electronics Remove Patients Remove Telehealth
article thumbnail

Predicting Likelihood of Missed Appointments in Primary Care [Health care informatics]

Annals of Family Medicine

Despite efforts to improve patient-clinician relationships, access to care, and healthcare workflows, annual rates of missed appointments (MA) in the U.S Objective To evaluate the association between patient, health system, geosocial, and environmental factors on the likelihood of MA in Family Medicine clinics. for CA, 0.85

article thumbnail

Prescribing ADHD Meds by Telehealth Does Not Alter Risk for Substance Use Disorder Overall

Physician's Weekly

TUESDAY, June 17, 2025 (HealthDay News) — Receipt of a stimulant prescription for attention-deficit/hyperactivity disorder (ADHD) via telehealth is not associated with an increased risk for substance use disorder (SUD), according to a study published online June 11 in The American Journal of Psychiatry. Vinod Rao, M.D., Vinod Rao, M.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tobacco Use Screening In Community-Based Primary Care Clinics By Visit Modality During The Covid-19 Pandemic [Smoking cessation]

Annals of Family Medicine

Context: Primary care delivery was significantly impacted by COVID-19, with rapid deployment of telehealth after the United States’ national public health emergency (PHE) declaration in March 2020. In the years following the PHE, rates of screening for tobacco use decreased, particularly during telehealth visits.

article thumbnail

CDRH Seeks Public Comment on How to Increase Patient Access to At-Home Use Medical Technologies

FDA Law Blog

According to the announcement, enabling patients to access medical devices beyond traditional clinical settings can help close the healthcare gap by delivering care “directly to patients, wherever they are – at home, at work, in cities, in rural communities.” telemedicine and telehealth solutions (e.g.,

Medical 45
article thumbnail

Clinical Trials Join the Remote Work Revolution: FDA’s New Draft Guidance on Decentralized Clinical Trials

FDA Law Blog

Section 3606(a) of the Food and Drug Omnibus Reform Act (FDORA) directed FDA to “issue or revise draft guidance that includes recommendations to clarify and advance the use of decentralized clinical studies to support the development of drugs and devices,” not later than December 29, 2023. DHTs include monitoring instruments (e.g.,

Clinic 59
article thumbnail

As the Calendar Turns, Cybersecurity Remains Key Focus of Digital Health Enforcement

FDA Law Blog

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. More updates will follow here as trends develop in 2023. By John W.M. FDA has shown a willingness to intervene in this space.

article thumbnail

Anti-Asian Hate: Russell Jeung, Lingsheng Li, & Jessica Eng

GeriPal

Ongoing reports from patients about anti-Asian hate experiences Should clinicians screen for Anti-Asian hate? This question, while providing an opportunity to talk about direct and indirect experiences, can be asked of all patients, and opens the door to conversations about anti-semitism, islamophobia, or anti-Black racism.